Medical Research
Readdi Inc
DURHAM, NC
Total revenue
$1.5M
Total expenses
$553K
Net assets
$1.6M
Grants received
$250K
1 grants
EIN
883812342
Tax year
2023
Mission
The rapidly emerging antiviral drug development initiative (readdi) is a nonprofit biotechnology organization dedicated to preventing global catastrophes caused by viruses. It plays a clear, specific and central role in the widely accepted three-pronged pandemic preparedness approach involving diagnostics, therapeutics and vaccines. Readdi develops therapeutics.
Financials
FY 2023
Revenue
Expenses
People
13 listed
JAMES ROSEN
CEO
$266K
40 hrs/wk
WILLIAM FLETCHER FAIREY
EXECUTIVE VP OF BUSINESS
$101K
40 hrs/wk
J CHRISTOPHER CLEMENS
BOARD MEMBER
—
0.5 hrs/wk
LAURENT FRAISSE
BOARD MEMBER
—
0.3 hrs/wk
ANDY JOHNS
BOARD MEMBER
—
0.5 hrs/wk
PERRIN JONES
BOARD MEMBER
—
0.3 hrs/wk
JOHN BAMFORTH
BOARD MEMBER
—
0.5 hrs/wk
LYDIA OGDEN
BOARD MEMBER
—
0.5 hrs/wk
TOM SHANAHAN
BOARD MEMBER
—
0.4 hrs/wk
BARBARA STEPHENSON
BOARD MEMBER
—
0.5 hrs/wk
BRAD WILKEN
BOARD MEMBER
—
0.3 hrs/wk
NATHAN KNUFFMAN
BOARD MEMBER
—
0.4 hrs/wk
RICHARD BURR
BOARD MEMBER
—
0.5 hrs/wk
Grants received
Showing 1 of 1
Funded by
$250K from 1 funder · 1 grant · 2023
$250K · 1 grant · 2023